Elekta AB (publ)

EKTA-B · Nasdaq Stockholm · Healthcare

51.60SEK −0.9%last day

Price as of 2 October 2026

The price over the past year, with dividends: +13.5%

Performance

1 month

−0.4%

1 year

+13.5%

3 years, per year

−7.6%

5 years, per year

−8.8%

Largest fall, 3 years

−48.5%

Below the peak now

−54.8%

Volatility, 1 year

41.3%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

2.6

Dividend yield

4.7%

Return on equity

−4.8%

Net margin

−2.2%

Market value

2.0 bn USD

Quality, value and trend

Where Elekta stands against every Nordic stock today. 100 is best.

Quality25

Profitability and a sound balance sheet over time. Better than 25% of Nordic stocks.

Value37

The price measured against earnings, assets and cash flow. Better than 37% of Nordic stocks.

Trend57

The price development over the past year. Better than 57% of Nordic stocks.

Combined29

Quality, value and trend together. Better than 29% of Nordic stocks.

About Elekta

Elekta AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 4,000 employees.

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis